{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447742786
| IUPAC_name = 10-chloro-''N''-(cyclopropylmethyl)-3-hydroxy-2-phenyl-3,6-diazabicyclo[5.4.0]undeca-1,6,8,10-tetraen-5-imine
| image = Cyprazepam.svg
| width = 222
| image2 = Cyprazepam3d.png
| width2 = 190

<!--Clinical data-->
| tradename =  
| pregnancy_category =
| legal_US = Schedule IV
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism = [[Liver|Hepatic]]
| elimination_half-life =
| excretion = [[Kidney|Renal]]

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 15687-07-7
| ATC_prefix = none
| PubChem = 27452
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16736916
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104165
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 933N61G4SL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03631

<!--Chemical data-->
| C=19 | H=18 | Cl=1 | N=3 | O=1 
| molecular_weight = 339.819 g/mol
| smiles = ClC1=CC2=C(N/C(C[N+]([O-])=C2C3=CC=CC=C3)=N/CC4CC4)C=C1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H18ClN3O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)23(24)12-18(22-17)21-11-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2,(H,21,22)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UKFDTMNJMKWWNK-UHFFFAOYSA-N
}}

'''Cyprazepam'''<ref>US Patent 3138586</ref> is a drug which is a [[sedative]]-[[hypnotic]] [[benzodiazepine]] derivative.<ref>{{cite journal |author=Herbert Oelschläger |author2=Doris Martienssen |author3=F. Belal  |date=22 September 2006 |title=Ring Contraction of 1,4-Benzodiazepines to 3,4-Dihydroquinazolines During Macro Scale Reduction (Example 5: Cyprazepam) |journal=Archiv der Pharmazie |volume=325 |issue=8 |pages=503–507 |publisher=Wiley Interscience |doi=10.1002/ardp.19923250810 |url=http://www3.interscience.wiley.com/journal/113348763/abstract |issn=0365-6233 }}</ref><ref>{{cite web |first= |last= |author=Bradley Matthews |author2=Shashoua Victor |author3=Webb Nigel |author4=Swindell Charles  |title=DHA-pharmaceutical agent conjugates -  European Patent Application EP1466628 |url=http://www.freepatentsonline.com/EP1466628.html |publisher=Patents online |date= 13 October 2004 |accessdate=19 September 2009}}</ref><ref>{{cite web |title=Harmonized Tariff Schedule of the United States (2009) - Supplement 1 - PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE |url=http://www.usitc.gov/publications/docs/tata/hts/bychapter/0910PHARMAPPX.pdf |publisher=United States International Trade Commission |location=USA |format=PDF |year=2009 |accessdate=19 September 2009 |deadurl=yes |archiveurl=https://web.archive.org/web/20090731024827/http://www.usitc.gov/publications/docs/tata/hts/bychapter/0910PHARMAPPX.pdf |archivedate=31 July 2009 |df= }}</ref><ref>{{cite journal |author=E. W. Schafer |author2=W. A. Bowles, Jr |author3=J. Hurlbut |title=The Acute Oral Toxicity, Repellency, and Hazard Potential of 998 Chemicals to One or More Species of Wild and Domestic Birds |url=http://www.springerlink.com/content/q3r47rn103727752/fulltext.pdf |year= 1983|journal=Arch. Environ. Contam. Toxicol. |volume=12 |pages=355–382 |format=PDF |location=USA |pmid=6882015 |doi=10.1007/BF01059413|accessdate=19 September 2009 |issue=3}}</ref> It has anxiolytic properties,<ref>{{cite web |author=World Health Organisation |title=The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances |url=http://www.moh.gov.sy/Pages/DrugAndNutrition/documents/INN%20Stems/RevisedFinalStemBook2006.pdf |publisher=Ministry of health, [[Syria]] |location=USA |format=PDF |year=2006 |accessdate=19 September 2009}} {{Dead link|date=November 2010|bot=H3llBot}}</ref> and presumably also has [[hypnotic]], [[skeletal muscle relaxant]], [[anticonvulsant]] and [[amnestic]] properties.

==Synthesis==
The [[lactam]] moiety in benzodiazepams is active towards nucleophiles and numerous analogues have been made by exploiting this fact.
[[File:Cyprazepam synthesis.svg|thumb|center|500px|Cyprazepam synthesis:<ref>H. M. Wuest, {{US Patent|3,138,586}} (1964);
Chem. Abstr., 61: 7,032f (1964).</ref>]]
For example, heating [[demoxepam]] with N-cyclopropylmethylamine leads to [[amidine]] formation, the minor tranquilizer cyprazepam.

==See also==
*[[Benzodiazepine]]

==References==
{{reflist}}

{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]


{{sedative-stub}}